Blockchain Registration Transaction Record

Branded Legacy Advances Low-Cost Naloxone Spray to Combat Opioid Crisis

Branded Legacy develops low-cost naloxone spray to combat opioid crisis. New intranasal delivery platform aims to match Narcan performance while improving global accessibility and reducing costs significantly.

This development represents a crucial advancement in addressing the ongoing opioid epidemic that has claimed hundreds of thousands of lives globally. The availability of affordable, accessible naloxone could dramatically reduce overdose fatalities by making this life-saving medication more widely distributed to first responders, community organizations, and individuals at risk. Current naloxone products often face cost barriers that limit their deployment in underserved communities most affected by the crisis. A lower-cost alternative could enable broader distribution through public health programs, schools, and community centers, potentially saving countless lives. The timing is particularly significant as opioid-related deaths continue to rise in many regions, making accessible overdose reversal treatments more urgent than ever for public health systems and affected communities.